MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

1.31
Delayed Data
As of Apr 24
 +0.08 / +6.50%
Today’s Change
1.05
Today|||52-Week Range
6.90
-37.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues314.2K1.3M148.1K0.00
 
 
 
 
Depreciation And Amortization12.2K21.4K96.6K159.8K
 
 
 
 
 
 
Operating ExpensesGross Income-------159.8K
 
 
General Expenses8.7M19.4M16.7M17.9M
 
 
 
 
 
Research And Development3.5M9.6M7.8M7.5M
 
 
 
 
 
Total Operating Expenses8.7M19.4M16.8M18.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.4M-18.1M-16.7M-18.1M
 
 
 
 
 
Extraordinary Credit475.4K19.8K0.000.00
 
 
 
Interest Expense On Debt0.000.00997.4K950.8K
 
 
 
Other Expenses-380.00-230.000.00540.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.9M-18.1M-17.7M-19.0M
 
 
 
 
 
Preferred Dividend-2.7M-17.9M0.00-13.8M
 
 
 
 
Net Income-7.9M-18.1M-17.7M-19.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.1K893.9K8.1M3.8M
 
 
 
 
 
Shares To Calculate EPS Diluted50.1K893.9K8.1M3.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$211.12-$40.40-$10.92-$8.56
 
 
 
 
 
EPS Diluted-$211.12-$40.40-$2.19-$8.56